Clinical trials although methodically planned, can run into serious operational, data, regulatory, or recruitment challenges, even when they have been carefully planned. From resource shortages and unforeseen service needs to contractual issues, recruitment problems and adverse events, these challenges can bring even the most carefully planned trials to a grinding halt. With strict deadlines, limited budgets and often tight resources, it can be difficult to determine the exact problem, particularly when time is of the essence. These challenges do not have to signify the end of the road. A rescue study, when planned and implemented promptly, can help sponsors reassess the trial, address the most urgent risks, and bring the study back under control.
In Brief
- A rescue study is a corrective intervention used when a clinical trial is at risk because of data quality, regulatory, operational, recruitment, vendor, or timeline issues.
- In clinical data management, rescue studies often focus on protecting data integrity, reviewing EDC setup, resolving query backlogs, managing database transitions, and restoring confidence in the data.
- Early root-cause assessment is essential before making changes, as the right rescue route depends on whether the issue sits with the protocol, sites, vendors, systems, data flow, or reporting readiness.
- Sponsors should prepare clear handover documentation, including data management plans, CRFs, edit checks, database configuration details, coding information, vendor contacts, validation evidence, and known data issues.
- A rescue study can help regain control of a trial, but it should be managed with realistic expectations around timelines, cost, residual data limitations, regulatory scrutiny, and documentation requirements.
What is a Rescue Study?
A rescue study in clinical research is a corrective intervention initiated when a clinical trial encounters significant challenges or shows early analysis indications that it may not demonstrate required drug efficacy. These challenges often include questionable data quality and integrity, regulatory non-compliance, missed deadlines, and overall mismanagement. These may include vendor performance issues, recruitment delays, resource constraints, or operational misalignment. The aim of a rescue study is to swiftly address and rectify these issues, ensuring the trial can proceed effectively. This may involve revising the trial's plan, enhancing participant recruitment and management, ensuring accurate data collection, and resolving any operational or resource-related difficulties. The goal is to safeguard the investment in the trial and support the reliability of the results.
Rescue Studies in Clinical Data Management
Rescue studies in clinical data management focus on protecting the quality, integrity, and usability of trial data when an ongoing study is at risk. In this context, the issue may not be the protocol itself, but the way data is being collected, managed, transferred, cleaned, validated, or prepared for analysis.
Common triggers include an electronic data capture, or EDC, system that has not been built correctly, incomplete or inconsistent data, gaps in edit checks, delays in query resolution, protocol-to-CRF mismatches, weak data transfer processes, or limited oversight of external data sources. A rescue may also be needed during a vendor transition, acquisition, redesign, or handover where database ownership, access rights, system configuration, and documentation need to be clarified quickly.
The first step is to understand the current state of the data and systems before making changes. This may include reviewing protocol and CRF alignment, annotated CRFs, the data management plan, data review plan, edit check specifications, coding dictionaries, lab ranges, vendor data transfer agreements, user roles, training records, and any linked modules such as randomisation, drug dispensation, or safety reporting.
Sponsors may then need to choose the most suitable database transition route. In some cases, the existing database URL can be transferred to the incoming CRO. In others, the outgoing vendor may need to retain administrative control while the new team manages data cleaning and queries. Where the database is not fit for purpose, a new database build may be required, with careful planning around data migration, discrepancy handling, validation, and combined datasets for analysis.
Any database changes should be controlled through sponsor approval, programming updates, user acceptance testing, user access review, test patient entry where appropriate, and a clear go-live decision. Once the transition is complete, the focus moves back to routine data cleaning, query management, listings, metrics, reconciliations, ad hoc reporting, and trial master file documentation.
A clinical data management rescue can help recover control of a study, but it cannot remove every limitation. Time pressure, incomplete documentation, residual data issues, cost, resource constraints, and potential bias all need to be considered when setting realistic expectations.
How to Rescue a Clinical Trial
Getting a study back on track involves several key steps. Firstly, a thorough evaluation is required to identify the specific issues plaguing the trial, then develop a detailed rescue plan tailored to these issues. This assessment should establish the root cause before corrective action begins, including whether the main issue sits in recruitment, site performance, protocol design, vendor performance, data quality, database configuration, or reporting readiness. This might include the points listed above, as well as improving participant retention, reallocating resources effectively, clarifying communication among all stakeholders for better coordination, and steps to ensure quality data.
The rescue plan could include revising the trial design where necessary, enhancing participant recruitment strategies, and ensuring accurate and reliable data collection methods are in place. Input from biostatistics, clinical data management, statistical programming, and database programming teams can help determine whether the issue is analytical, operational, data-driven, or system-related. This may include reviewing the statistical analysis plan, data validation approach, database configuration, edit checks, data transfer specifications, and reporting requirements. These approaches help in rectifying data integrity issues and adapting the trial design to changing conditions, thus supporting the reliability of the trial outcomes. Additionally, addressing operational or resource-related difficulties is essential to get the trial back on track.
Once the clinical trial is back up and running, it’s important to continuously monitor the trial’s progress and make necessary adjustments to keep it aligned for success. The objective of the rescue study is not just to salvage the investment in the trial, but also to protect the reliability and validity of its results. As this process can often be complex, consulting with external experts or partnering with a specialised Clinical Research Organisation (CRO) experienced in rescuing clinical trials can be beneficial. The success of a rescue operation depends on a tailored approach and proactive management.
Planning and Preparation
Early intervention is crucial when setting in motion a rescue study for a clinical trial. Often, the trial may already be facing considerable delays, making it a priority to regain progress rapidly and effectively. A thorough comprehension of the entire trial process and the specific areas requiring intervention is essential.
Here are some important considerations to keep in mind when mapping out your rescue study strategy:
- Allocate sufficient time and gather necessary information for obtaining approval from management before engaging with the existing central lab.
- Gather internal support for the rationale behind the rescue.
- Evaluate and plan for the impact on all stakeholders involved.
- Clearly outline and understand your budgetary needs.
- Establish timelines and develop transition plans.
- Gather information on data type, data updates needed, types of validation to be performed, whether data is locked/unblinded/to be reopened, and number of reports and types of reports to get generated.
In selecting a rescue CRO, it's important to choose one that aligns with the specific requirements of your rescue study. Each clinical trial has unique needs, and the chosen intervention should be customised to meet these specific requirements.
Database Transfer and Validation in Rescue Studies
Database transfer is one of the most important decisions in a clinical data management rescue. The right route depends on the current system, ownership rights, configuration limitations, linked modules, the amount of data already collected, and how urgently the next analysis or reporting milestone is needed.
There are usually three broad options. The existing database may be transferred to the incoming CRO, allowing the new team to continue work within the same environment. The original vendor may retain database administration while the incoming CRO takes responsibility for data cleaning, query management, reporting, or oversight. Alternatively, a new database may be built if the current structure is no longer fit for purpose.
Each option carries practical implications. A direct transfer may be quicker, but system configuration settings may not be fully editable if they are owned by the outgoing CRO or vendor. Leaving administration with the existing vendor can reduce immediate disruption, but it requires clear governance and communication. A new database can solve structural problems, but it may require data migration, manual re-entry or programmatic remapping, discrepancy resolution, validation, and careful documentation for analysis and audit readiness.
Before routine data cleaning resumes, any database updates should go through a controlled process. This typically includes sponsor approval, programming changes, user acceptance testing, user role and access checks, training confirmation, test patient entry where relevant, and a documented go-live decision. This helps ensure the rescue does not introduce new data integrity risks while trying to resolve existing ones.
The Additional Regulatory Challenges Once Rescue is Needed
When a clinical trial enters a rescue study phase, it’s no surprise this will also mean several additional regulatory challenges, each necessitating careful management to ensure the trial's compliance and integrity.
These can be summarised in six key areas:
-
Protocol Amendments
Rescue studies often require significant changes to the initial trial protocol, and these amendments must undergo a rigorous approval process with regulatory bodies. This process, while essential for maintaining scientific rigor, can be time-consuming and requires precise alignment with regulatory standards. -
Informed Consent
Updating informed consent documents are necessary to reflect the altered conditions of the study, ensuring that participants are fully aware of and consent to the new terms. This step entails additional ethical reviews and approvals, emphasizing the protection of patient rights and safety. -
Frequent updates to regulatory agencies
The shift to a rescue phase also often leads to increased scrutiny from regulatory agencies. These bodies may demand more frequent updates and in-depth information about the trial's progress, specifically focusing on the effectiveness of the measures implemented to address the initial issues. This heightened oversight ensures that the trial remains compliant with regulatory requirements throughout its altered course. -
Data integrity
Another significant challenge is ensuring the integrity and continuity of data collected both before and after the rescue intervention. Regulators will scrutinise this data closely, assessing the validity of the trial's outcomes, especially if the rescue plan involved substantial modifications. For data management rescue work, this means maintaining traceability across database changes, documenting data transfers, retaining audit trails, and explaining how discrepancies were identified, reviewed, and resolved. -
Multiple regulatory agencies
For trials that span multiple regions, aligning the rescue strategy with the diverse regulations of different countries presents an additional layer of complexity, which is one of the reasons seeking the help of an expert or specialist CRO can be beneficial. Each region has its unique set of regulatory demands and approval processes, which must be carefully navigated to maintain compliance across all jurisdictions. -
Transparency
Lastly, the entire process demands a high level of transparency and detailed reporting. Regulatory bodies require comprehensive accounts of why the rescue was necessary, the steps taken to rectify the issues, and the outcomes of these interventions. The ethical implications of changes made during the rescue phase must be meticulously considered, focusing on patient safety, data validity, and the scientific integrity of the trial. Successfully working your way through these multifaceted regulatory challenges requires a deep understanding of the regulatory requirements, effective communication with relevant authorities, and diligent planning and documentation throughout the rescue process.
Help Your Chosen CRO Succeed
To assist your chosen CRO in a smooth handover with no further delays, it’s important to supply them with all of the information and data they need in a transparent and detailed format, so they can understand the current state of your clinical trial.
Our team of specialists suggest you supply the following details:
Data Pertaining to the Rescue Study
- Comprehensive list and details of all involved sites, including their locations and the status of their IRB/ethics approvals.
- Progress updates for each site's initial setup, encompassing contract details and IRB/ethics status.
- Current status of active sites, particularly those with enrolled patients.
- Information on any new sites or countries being considered for inclusion.
- Current status of grant payments, specifying what has been paid and what is pending.
- Current data management documentation, including DMP, CRFs, etc.
Information on Patient Management
- Detailed reports on site and patient monitoring activities, including any data gathered to date, requirements for additional monitoring or sample collection, and plans for future monitoring.
- An overview of patient engagement strategies, including the effectiveness of existing tools, potential enhancements, and patient-centred approaches like travel assistance and reimbursement methods.
Regulatory and Data Protection Information
- Details about legal representation within the European Union.
- Agreements related to data controller and processor roles under GDPR.
- Information on the ownership and status of insurance policies.
- Status of trial master file documentation linked to data management, database changes, validation evidence, approvals, and vendor handover decisions.
Risks and Limits of Rescue Studies
A rescue study can help a sponsor regain control, but it should not be presented as a simple reset. Some issues may be recoverable, while others may leave limitations that need to be documented and accounted for in analysis, reporting, and regulatory communication.
Common risks include compressed timelines, increased cost, competing resource demands, incomplete handover documentation, residual data quality issues, delayed query resolution, and uncertainty around how earlier operational problems may affect interpretation. Where data have already been collected under inconsistent processes, the rescue plan should make clear what can be corrected, what can be verified, and what must be acknowledged as a limitation.
This is why early assessment matters. The sooner a sponsor understands the source and scale of the problem, the more realistic the recovery plan can be.
Conclusion
Recovering a clinical trial with a rescue study can feel complex, but a structured reassessment can help identify where the study is at risk and what needs to change.
The involvement of a specialised CRO with expertise in rescue operations can be beneficial, offering the guidance and resources necessary to navigate a trial through the unexpected roadblocks. The process requires a high degree of transparency and regulatory rigor, particularly when faced with the additional regulatory challenges during a rescue study.
With clear planning, controlled data management, document decision-making and realistic expectations, a rescue study can help protect data integrity and support more reliable trial delivery.
At Quanticate, our experienced team of experts can assess the current state of your study and support rescue work across clinical data management, biostatistics, statistical programming, and medical writing. For more information contact us and speak to a member of our team by requesting a consultation below.
